SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-17-001066
Filing Date
2017-05-01
Accepted
2017-05-01 16:15:03
Documents
4
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDED ANNUAL REPORT xenetic_10ka1-123116.htm 10-K/A 254646
2 SUBSIDIARIES OF REGISTRANT xenetic_10ka1-ex2101.htm EX-21.1 2024
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER xenetic_10ka1-ex3101.htm EX-31.1 4232
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER xenetic_10ka1-ex3102.htm EX-31.2 4087
  Complete submission text file 0001683168-17-001066.txt   266189
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37937 | Film No.: 17800877
SIC: 2834 Pharmaceutical Preparations